Home/Filings/8-K/0001640334-26-000005
8-K//Current report

ARTELO BIOSCIENCES, INC. 8-K

Accession 0001640334-26-000005

$ARTLCIK 0001621221operating

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:17 PM ET

Size

143.2 KB

Accession

0001640334-26-000005

Research Summary

AI-generated summary of this filing

Updated

Artelo Biosciences Adjourns 2025 Annual Meeting; Reconvenes Jan 30, 2026

What Happened

  • Artelo Biosciences, Inc. announced that its 2025 annual meeting of stockholders, convened on December 31, 2025, was adjourned without conducting any business due to insufficient votes to constitute a quorum.
  • The meeting will reconvene virtually at 8:00 a.m. Pacific Time on Friday, January 30, 2026 via live audio webcast at https://www.proxyvote.com/. The company expects to add a proposal to ratify Malone Bailey LLP as independent auditor for the fiscal year ending December 31, 2026.

Key Details

  • Adjournment date: December 31, 2025 (no business conducted).
  • Reconvened meeting: January 30, 2026 at 8:00 a.m. PT, virtual webcast.
  • Record date for voting remains December 10, 2025.
  • Proxies already submitted will be voted at the reconvened meeting unless properly revoked; supplemental proxy materials and a revised proxy card will be filed and mailed to stockholders for the anticipated auditor ratification proposal.

Why It Matters

  • The adjournment delays shareholder votes on company proposals and gives stockholders more time to submit proxies.
  • Adding an auditor ratification vote (Malone Bailey LLP) is a governance item that stockholders will be asked to approve at the reconvened meeting.
  • Investors who already voted do not need to take action unless they want to change their vote; those who have not voted have until the reconvened meeting to participate.